Cowen Prime Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $176K | Sell |
1,304
-1,200
| -48% | -$176K | 0.06% | 91 |
|
|
2023
Q1 | $378K | Buy |
2,504
+50
| +2% | +$7.64K | 0.15% | 64 |
|
|
2022
Q4 | $397K | Buy |
2,454
+2,150
| +707% | +$330K | 0.16% | 61 |
|
|
2022
Q3 | $41K | Hold |
304
| – | – | 0.02% | 115 |
|
|
2022
Q2 | $47K | Hold |
304
| – | – | 0.03% | 117 |
|
|
2022
Q1 | $49K | Hold |
304
| – | – | 0.02% | 125 |
|
|
2021
Q4 | $41K | Hold |
304
| – | – | 0.01% | 126 |
|
|
2021
Q3 | $33K | Hold |
304
| – | – | 0.01% | 129 |
|
|
2021
Q2 | $34K | Hold |
304
| – | – | 0.01% | 123 |
|
|
2021
Q1 | $33K | Hold |
304
| – | – | 0.01% | 124 |
|
|
2020
Q4 | $33K | Hold |
304
| – | – | 0.01% | 124 |
|
|
2020
Q3 | $27K | Hold |
304
| – | – | 0.01% | 133 |
|
|
2020
Q2 | $47K | Buy |
304
+4
| +1% | +$352 | 0.03% | 117 |
|
|
2020
Q1 | $23K | Hold |
300
| – | – | 0.01% | 132 |
|
|
2019
Q4 | $27K | Hold |
300
| – | – | 0.01% | 127 |
|
|
2019
Q3 | $23K | Hold |
300
| – | – | 0.01% | 129 |
|
|
2019
Q2 | $22K | Hold |
300
| – | – | 0.01% | 136 |
|
|
2019
Q1 | $24K | Sell |
300
-500
| -63% | -$40.9K | 0.01% | 136 |
|
|
2018
Q4 | $74K | Hold |
800
| – | – | 0.04% | 106 |
|
|
2018
Q3 | $76K | Hold |
800
| – | – | 0.04% | 127 |
|
|
2018
Q2 | $74K | Buy |
800
+200
| +33% | +$19.5K | 0.04% | 122 |
|
|
2018
Q1 | $57K | Sell |
600
-200
| -25% | -$22K | 0.03% | 134 |
|
|
2017
Q4 | $77K | Hold |
800
| – | – | 0.04% | 127 |
|
|
2017
Q3 | $71K | Sell |
800
-28,485
| -97% | -$2.17M | 0.03% | 119 |
|
|
2017
Q2 | $2.12M | Sell |
29,285
-1,100
| -4% | -$74K | 0.98% | 32 |
|
|
2017
Q1 | $1.98M | Sell |
30,385
-19,965
| -40% | -$1.26M | 1.02% | 31 |
|
|
2016
Q4 | $3.15M | Hold |
50,350
| – | – | 1.7% | 15 |
|
|
2016
Q3 | $3.18M | Sell |
50,350
-6,250
| -11% | -$405K | 1.44% | 18 |
|
|
2016
Q2 | $3.5M | Sell |
56,600
-4,915
| -8% | -$299K | 1.7% | 16 |
|
|
2016
Q1 | $3.51M | Sell |
61,515
-1,035
| -2% | -$57.7K | 1.63% | 17 |
|
|
2015
Q4 | $3.71M | Buy |
62,550
+900
| +1% | +$51.8K | 1.64% | 19 |
|
|
2015
Q3 | $3.35M | Buy |
61,650
+7,229
| +13% | +$471K | 1.57% | 19 |
|
|
2015
Q2 | $3.66M | Sell |
54,421
-461
| -0.8% | -$30.1K | 1.43% | 17 |
|
|
2015
Q1 | $3.21M | Buy |
54,882
+7,578
| +16% | +$458K | 1.32% | 20 |
|
|
2014
Q4 | $3.1M | Buy |
47,304
+7,604
| +19% | +$479K | 1.22% | 21 |
|
|
2014
Q3 | $2.29M | Buy |
39,700
+34,405
| +650% | +$1.91M | 1% | 22 |
|
|
2014
Q2 | $299K | Buy |
5,295
+5
| +0.1% | +$262 | 0.12% | 74 |
|
|
2014
Q1 | $272K | Buy |
5,290
+4
| +0.1% | +$202 | 0.1% | 81 |
|
|
2013
Q4 | $279K | Buy |
5,286
+5
| +0.1% | +$246 | 0.11% | 84 |
|
|
2013
Q3 | $237K | Buy |
5,281
+90
| +2% | +$3.99K | 0.09% | 104 |
|
|
2013
Q2 | $216K | Buy |
+5,191
| New | +$227K | 0.09% | 104 |
|
Other funds holding ABBV
Cowen Prime Advisors's ABBV Position: Q2 2023 in Review
Cowen Prime Advisors reduced its AbbVie (ABBV) stake by 48% in Q2 2023, selling an estimated $176K and leaving 1,304 shares worth $176K. The position accounts for 0.06% of the portfolio, ranked #91.
Cowen Prime Advisors first reported a position in ABBV in Q2 2013 and has held it in 41 quarters since. The position peaked at $3.71M in Q4 2015. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.
- Cowen Prime Advisors held 1,304 shares of AbbVie worth $176K as of Q2 2023.
- Cowen Prime Advisors sold 1,200 AbbVie shares in Q2 2023, an estimated $176K.
- AbbVie made up 0.06% of Cowen Prime Advisors's portfolio in Q2 2023, its #91 holding.
- Cowen Prime Advisors first reported a position in AbbVie in Q2 2013 and has held it in 41 quarters since.
- Cowen Prime Advisors's AbbVie position peaked at $3.71M in Q4 2015.
- 3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.
Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.